Biotechnology company Illumina, Inc. (NASDAQ: ILMN) on Wednesday announced financial results for the second quarter of 2023.
- Second-quarter revenue came in at $1.18 billion, up 1% from Q2 2022; a 3% increase on a constant currency basis
- Net loss per share was $1.48 in Q2, compared to a loss per share of $3.40 in the year-ago quarter
- On an adjusted basis, it was earnings of $0.32 per share for Q2 2023, compared to $0.57 per share last year
- The company expects fiscal year 2023 consolidated revenue growth of approximately 1%
- It is looking for a loss in the range of $2.08 per share to $1.93 per share for fiscal 2023
- Full-year adjusted earnings per share is expected to be in the range of $0.75 to $0.90
Most Popular
DAL Earnings: All you need to know about Delta Air Lines’ Q1 2025 earnings results
Delta Air Lines (NYSE: DAL) reported its first quarter 2025 earnings results today. Operating revenue increased 2% year-over-year to $14 billion. Net income was $240 million, or $0.37 per share,
Deals and R&D in focus as Johnson & Johnson gears up for Q1 earnings
For Johnson & Johnson (NYSE: JNJ), investments in its pipeline and exiting lower priority businesses remain central to its strategy in the new fiscal year. The healthcare behemoth is in
Earnings preview: What to expect when these major banks report Q1 2025 results
The leading players in the banking industry are set to report their earnings results for the first quarter of 2025 over this week and the next. While majors JPMorgan Chase
